Logo image of RWLK

REWALK ROBOTICS LTD (RWLK) Stock Fundamental Analysis

NASDAQ:RWLK - Nasdaq - IL0011331076 - Common Stock - Currency: USD

1.0501  +0.06 (+6.07%)

After market: 1.0798 +0.03 (+2.83%)

Fundamental Rating

3

RWLK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. The financial health of RWLK is average, but there are quite some concerns on its profitability. RWLK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RWLK has reported negative net income.
RWLK had a negative operating cash flow in the past year.
In the past 5 years RWLK always reported negative net income.
In the past 5 years RWLK always reported negative operating cash flow.
RWLK Yearly Net Income VS EBIT VS OCF VS FCFRWLK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -31.49%, RWLK is in line with its industry, outperforming 42.21% of the companies in the same industry.
RWLK has a Return On Equity (-42.10%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -31.49%
ROE -42.1%
ROIC N/A
ROA(3y)-28.68%
ROA(5y)-58.96%
ROE(3y)-34.19%
ROE(5y)-271.73%
ROIC(3y)N/A
ROIC(5y)N/A
RWLK Yearly ROA, ROE, ROICRWLK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -200 -400 -600 -800 -1K

1.3 Margins

RWLK has a worse Gross Margin (29.29%) than 73.37% of its industry peers.
RWLK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RWLK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-2.82%
RWLK Yearly Profit, Operating, Gross MarginsRWLK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -200 -400 -600

More info and screens

6

2. Health

2.1 Basic Checks

RWLK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RWLK has less shares outstanding
There is no outstanding debt for RWLK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RWLK Yearly Shares OutstandingRWLK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
RWLK Yearly Total Debt VS Total AssetsRWLK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -2.88, we must say that RWLK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.88, RWLK is doing worse than 64.82% of the companies in the same industry.
RWLK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.88
ROIC/WACCN/A
WACC8.59%
RWLK Yearly LT Debt VS Equity VS FCFRWLK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M 60M 80M

2.3 Liquidity

RWLK has a Current Ratio of 3.47. This indicates that RWLK is financially healthy and has no problem in meeting its short term obligations.
RWLK has a Current ratio of 3.47. This is comparable to the rest of the industry: RWLK outperforms 53.27% of its industry peers.
RWLK has a Quick Ratio of 3.00. This indicates that RWLK is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of RWLK (3.00) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.47
Quick Ratio 3
RWLK Yearly Current Assets VS Current LiabilitesRWLK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for RWLK have decreased strongly by -27.59% in the last year.
The Revenue has grown by 99.78% in the past year. This is a very strong growth!
The Revenue has been decreasing by -6.60% on average over the past years.
EPS 1Y (TTM)-27.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
Revenue 1Y (TTM)99.78%
Revenue growth 3Y4.2%
Revenue growth 5Y-6.6%
Sales Q2Q%394.38%

3.2 Future

Based on estimates for the next years, RWLK will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.76% on average per year.
The Revenue is expected to grow by 65.46% on average over the next years. This is a very strong growth
EPS Next Y-21.12%
EPS Next 2Y-8.6%
EPS Next 3Y4.45%
EPS Next 5Y8.76%
Revenue Next Year162.79%
Revenue Next 2Y147.47%
Revenue Next 3Y98.35%
Revenue Next 5Y65.46%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RWLK Yearly Revenue VS EstimatesRWLK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
RWLK Yearly EPS VS EstimatesRWLK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60 -80

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RWLK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RWLK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RWLK Price Earnings VS Forward Price EarningsRWLK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RWLK Per share dataRWLK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.6%
EPS Next 3Y4.45%

More info and screens

0

5. Dividend

5.1 Amount

RWLK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REWALK ROBOTICS LTD

NASDAQ:RWLK (1/29/2024, 8:00:03 PM)

After market: 1.0798 +0.03 (+2.83%)

1.0501

+0.06 (+6.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2023-11-14/bmo
Earnings (Next)02-22 2024-02-22/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners28.31%
Ins Owner Change0%
Market Cap63.03M
Analysts82.86
Price Target3.06 (191.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.95%
Min EPS beat(2)-15.86%
Max EPS beat(2)-12.04%
EPS beat(4)1
Avg EPS beat(4)-9.94%
Min EPS beat(4)-26.05%
Max EPS beat(4)14.22%
EPS beat(8)1
Avg EPS beat(8)-30.34%
EPS beat(12)3
Avg EPS beat(12)-22.1%
EPS beat(16)4
Avg EPS beat(16)-20.52%
Revenue beat(2)1
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)0.32%
Revenue beat(4)2
Avg Revenue beat(4)-9.16%
Min Revenue beat(4)-39.71%
Max Revenue beat(4)4.36%
Revenue beat(8)2
Avg Revenue beat(8)-26.74%
Revenue beat(12)5
Avg Revenue beat(12)-15.29%
Revenue beat(16)6
Avg Revenue beat(16)-14.37%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.89
P/FCF N/A
P/OCF N/A
P/B 1.22
P/tB 2.04
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.15
BVpS0.86
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.49%
ROE -42.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.29%
FCFM N/A
ROA(3y)-28.68%
ROA(5y)-58.96%
ROE(3y)-34.19%
ROE(5y)-271.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-2.82%
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.47
Quick Ratio 3
Altman-Z -2.88
F-Score4
WACC8.59%
ROIC/WACCN/A
Cap/Depr(3y)19.22%
Cap/Depr(5y)13.22%
Cap/Sales(3y)0.99%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
EPS Next Y-21.12%
EPS Next 2Y-8.6%
EPS Next 3Y4.45%
EPS Next 5Y8.76%
Revenue 1Y (TTM)99.78%
Revenue growth 3Y4.2%
Revenue growth 5Y-6.6%
Sales Q2Q%394.38%
Revenue Next Year162.79%
Revenue Next 2Y147.47%
Revenue Next 3Y98.35%
Revenue Next 5Y65.46%
EBIT growth 1Y-25.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-76.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.85%
OCF growth 3YN/A
OCF growth 5YN/A